A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Zentek Ltd. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 21,500 shares of ZTEK stock, worth $27,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,500
Holding current value
$27,735
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 22, 2025

BUY
$0.9 - $1.2 $19,350 - $25,800
21,500 New
21,500 $24,000
Q1 2022

May 12, 2022

BUY
$1.93 - $3.92 $20,265 - $41,160
10,500 New
10,500 $32,000

Others Institutions Holding ZTEK

About Zentek Ltd.


  • Ticker ZTEK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 99,363,104
  • Market Cap $128M
  • Description
  • Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detec...
More about ZTEK
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.